Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-09-11T02:44:41.735Z.
Calculation as of: 2026-09-11T02:44:41.735Z.
Quote observation: 2026-09-10T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d670d92a9ed985c4ba88d5830250f1e4eb43691fb1e0723b4e8904464d1c2daf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$10.45B
Operating Cash Flow Yield
3.49%
TTM Avg
3.95%
3Y Avg
4.64%
5Y Avg
7.09%
Market Cap
$10.46B
Operating Cash Flow Yield
17.22%
TTM Avg
16.10%
3Y Avg
14.19%
5Y Avg
12.75%
Market Cap
$10.07B
Operating Cash Flow Yield
6.04%
TTM Avg
5.07%
3Y Avg
4.87%
5Y Avg
5.31%
Market Cap
$10.56B
Operating Cash Flow Yield
1.73%
TTM Avg
6.04%
3Y Avg
4.48%
5Y Avg
4.33%
Market Cap
$9.94B
Operating Cash Flow Yield
7.04%
TTM Avg
6.53%
3Y Avg
7.10%
5Y Avg
6.80%
Market Cap
$9.93B
Operating Cash Flow Yield
4.96%
TTM Avg
6.32%
3Y Avg
5.36%
5Y Avg
4.41%
Market Cap
$9.92B
Operating Cash Flow Yield
9.18%
TTM Avg
6.85%
3Y Avg
5.10%
5Y Avg
4.44%
Market Cap
$10.79B
Operating Cash Flow Yield
7.00%
TTM Avg
5.85%
3Y Avg
4.77%
5Y Avg
4.23%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.29B | N/A | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.45B | 3.49% | 3.95% | 4.64% | 7.09% |
| Universal Health Services, Inc. (UHS)vs › | $10.46B | 17.22% | 16.10% | 14.19% | 12.75% |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 6.04% | 5.07% | 4.87% | 5.31% |
| The Cooper Companies, Inc. (COO)vs › | $10.56B | 1.73% | 6.04% | 4.48% | 4.33% |
| Henry Schein, Inc. (HSIC)vs › | $9.94B | 7.04% | 6.53% | 7.10% | 6.80% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 4.96% | 6.32% | 5.36% | 4.41% |
| Globus Medical, Inc. (GMED)vs › | $9.92B | 9.18% | 6.85% | 5.10% | 4.44% |
| Align Technology, Inc. (ALGN)vs › | $10.79B | 7.00% | 5.85% | 4.77% | 4.23% |
| Insulet Corp. (PODD)vs › | $9.33B | 5.48% | 3.81% | 2.34% | 1.86% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
